Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Statin Use Not Linked to Lower Prostate Cancer Risk, but Genetic Variants May Influence Outcomes: Study Suggests Medicine

Statin Use Not Linked to Lower Prostate Cancer Risk, but Genetic Variants May Influence Outcomes: Study Suggests

  • 02 November 2025
  • 38 minutes from now

GSK acquires exclusive rights from Syndivia for antibody drug conjugate in prostate cancer Pharma News

GSK acquires exclusive rights from Syndivia for antibody drug conjugate in prostate cancer

  • 28 October 2025
  • 4 days ago

Drug combo cuts risk of death in advanced prostate cancer by 40%: NEJM Oncology

Drug combo cuts risk of death in advanced prostate cancer by 40%: NEJM

  • 27 October 2025
  • 5 days ago

New Imaging Technique Detects Prostate Cancer Recurrence with 70 Percent Accuracy: Study Finds Oncology

New Imaging Technique Detects Prostate Cancer Recurrence with 70 Percent Accuracy: Study Finds

  • 17 October 2025
  • 2 weeks ago

JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer Pharma News

JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer

  • 17 October 2025
  • 2 weeks ago

ASTRO: New therapy delays progression of recurrent prostate cancer Oncology

ASTRO: New therapy delays progression of recurrent prostate cancer

  • 14 October 2025
  • 2 weeks ago

New drug combination offers hope for men with advanced prostate cancer: Study Oncology

New drug combination offers hope for men with advanced prostate cancer: Study

  • 13 October 2025
  • 2 weeks ago

First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer: Study Oncology

First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer: Study

  • 30 September 2025
  • 1 month ago

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva Obstetrics and Gynaecology

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

  • 23 September 2025
  • 1 month ago

New tracer could enable surgeons to see and hear prostate cancer: Study Oncology

New tracer could enable surgeons to see and hear prostate cancer: Study

  • 19 September 2025
  • 1 month ago

Recent News

SR Post VACANCIES At ESIC Model Hospital Noida, Ch...

  • 02 November, 2025

Pathologist's signature on medical reports not mus...

  • 02 November, 2025

UP Eyes Japanese Investment: 125 Pharma Giants Inv...

  • 02 November, 2025

Delhi Govt to recruit 1,593 senior resident doctor...

  • 02 November, 2025

Former Drug Inspector's Office Clerk Jailed for Ta...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.